Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 277 publications
Targeted α-synuclein mRNA degradation by PMO-based RNA-degrading chimeras.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 14, 2026
PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 15, 2026
Protocols for Assessing the Nuclease Activity of MIF.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 13, 2026
MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 22, 2026
Microglial Lag3 Drives α-Synuclein-induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
Neuronal PARIS-STAT3 axis drives tau pathology and glial activation in Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: December 22, 2025
Spatially Organized IGF1-mTOR Signaling Controls Human Forebrain Progenitor F ate Through Coordinated Transcriptional and Translational Programs.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Targeted α-Synuclein mRNA Degradation by PMO-Based RNA-Degrading Chimeras.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Cell death analysis of inducible, titratable neurodegenerative disease models in zebrafish and human stem cell-derived retinal organoids.
Journal: Disease models & mechanisms
Published: November 06, 2025
In-vivo iron mapping in patients with Parkinson's disease using deep learning-based susceptibility source separation MRI.
Journal: NPJ Parkinson's disease
Published: November 02, 2025
Last Updated: 09/26/2026